Germany, Italy and South Korea respectively were numbers 2, 3 and 4 in this ranking.
How does Sweden perform in Cardiovascular Drug?
Forecast: Antihypertensive Medicine Sales in Sweden
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Sweden
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Sweden
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Sweden
- Million Swedish Kronas
- 2024 to 2028
- ReportLinker Research
Forecast: Beta Blocking Medicine Sales in Sweden
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Antiarrhythmic Medicine Use in Sweden
- Units (Defined Daily Dosage) Per Thousand Persons Per Day
- 2024 to 2028
- ReportLinker Research
Forecast: Calcium Channel Blocking Medicine Sales in Sweden
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Diuretic Medicine Sales in Sweden
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Sweden
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Cardiac Glycosides Sales in Sweden
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research